Indus Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Pakistan pharmaceutical company with more than five decades of experience in branded generics, primary care and chronic-care medicines.
Indus Pharma products in Pakistan
Indus Pharma (Pvt.) Ltd has 62 medicine presentations registered in Pakistan under 24 brands, covering 23 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and CNS & mental health. Its brands with the most registered strengths and packs are Lecetam (Levetiracetam), Onseron (Ondansetron), Canter (Clarithromycin) and Ciplet (Ciprofloxacin). 62 products have an official DRAP price on MedInfoBase. See all 24 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. A-26, K.C.H.S. Union Commercial Area, Jinnah Housing Society, Karachi 75400, Pakistan · 75400
- Website
- indus-pharma.com ↗
- Phone
- +92 21 34535253; +92 21 34535254
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Indus Pharma (Pvt.) Ltd. is priced against the market
58 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Canter | Clarithromycin | 500 mg | Tablet | 10's | 048479 | PKR 919.06 | PKR 91.91/tablet | 🔒 Pharma Pro |
| Canter | Clarithromycin | 125 mg/5 mL | Oral suspension | 60ml | 048480 | PKR 460.57 | PKR 7.68/mL | 🔒 Pharma Pro |
| Canter | Clarithromycin | 125 mg/5 mL | Oral suspension | 25ml | 048480 | PKR 191.90 | PKR 7.68/mL | 🔒 Pharma Pro |
| Canter | Clarithromycin | 250 mg/5 mL | Oral suspension | 60ml | 082137 | PKR 749.32 | PKR 12.49/mL | 🔒 Pharma Pro |
| Cidpro | Omeprazole | 20 mg | Capsule | 14's | 053489 | PKR 297.39 | PKR 21.24/capsule | 🔒 Pharma Pro |
| Cidpro | Omeprazole | 40 mg | Capsule | 14's | 053490 | PKR 516.32 | PKR 36.88/capsule | 🔒 Pharma Pro |
| Cidpro | Omeprazole | 40 mg | Injection | 1's | 095076 | PKR 506.48 | PKR 506.48/vial/unit | 🔒 Pharma Pro |
| Ciplet | Ciprofloxacin | 250 mg | Tablet | 10's | 044461 | PKR 268.47 | PKR 26.85/tablet | 🔒 Pharma Pro |
| Ciplet | Ciprofloxacin | 200 mg/100 mL | IV infusion | 100ml Vial | 044463 | PKR 232.98 | PKR 2.33/mL | 🔒 Pharma Pro |
| Ciplet | Ciprofloxacin | 125 mg/5 mL | Suspension | 60ml | 073478 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| Ciplet | Ciprofloxacin | 250 mg/5 mL | Suspension | 60ml Bottle | 073479 | PKR 330.48 | PKR 5.51/mL | 🔒 Pharma Pro |
| Ciplet DS InfusionRegistry verified | Ciprofloxacin | — | — | — | 067629Official source ↗ | No indexed price | — | — |
| Dyclo 75mg/3ml IV/IM InjectionRegistry verified | Diclofenac Sodium | — | — | — | 012713Official source ↗ | No indexed price | — | — |
| Dyclo TabletRegistry verified | Diclofenac sodium | — | — | — | 012542Official source ↗ | No indexed price | — | — |
| Exef | Cefotaxime | 250 mg | Injection | 1's | 022444 | PKR 134.34 | PKR 134.34/vial/unit | 🔒 Pharma Pro |
| Explat | Clopidogrel | 75 mg | Tablet | 10 | 034065 | PKR 291.49 | PKR 29.15/tablet | 🔒 Pharma Pro |
| Flatox | Metronidazole | 500 mg | IV infusion | 100ml Vial | 039018 | PKR 189.93 | PKR 1.90/mL | 🔒 Pharma Pro |
| Indaz | Azithromycin | 250 mg | Capsule | 6's | 048477 | PKR 277.13 | PKR 46.19/capsule | 🔒 Pharma Pro |
| Indaz | Azithromycin | 250 mg | Capsule | 10's | 048477 | PKR 461.87 | PKR 46.19/capsule | 🔒 Pharma Pro |
| Indaz | Azithromycin | 200 mg/5 mL | Suspension | 30ml | 092649 | PKR 628.01 | PKR 20.93/mL | 🔒 Pharma Pro |
| Indaz | Azithromycin | 200 mg/5 mL | Suspension | 15ml | 092649 | PKR 320.35 | PKR 21.36/mL | 🔒 Pharma Pro |
| Indazole 20mg CapsulesRegistry verified | Esomeprazole, Esomeprazole (as esomeprazole magnesium trihydrate) | — | — | — | 042375Official source ↗ | No indexed price | — | — |
| Indazole 40mg CapsulesRegistry verified | Esomeprazole, Esomeprazole (as esomeprazole magnesium trihydrate) | — | — | — | 042376Official source ↗ | No indexed price | — | — |
| Indexo DDR Capsule 30mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole | — | — | — | 105341Official source ↗ | No indexed price | — | — |
| Indexo DDR Capsule 60mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole | — | — | — | 103180Official source ↗ | No indexed price | — | — |
| Indolact | Lactulose | 66.7 g/100 mL | Syrup | 120ml | 096179 | PKR 305.66 | PKR 2.55/mL | 🔒 Pharma Pro |
| Indopol 125mg Oral SuspensionRegistry verified | Cefadroxil (as Cefadroxil Monohydrate) | — | — | — | 042476Official source ↗ | No indexed price | — | — |
| Indopol 250mg Oral SuspensionRegistry verified | Cefadroxil (as Cefadroxil Monohydrate) | — | — | — | 042477Official source ↗ | No indexed price | — | — |
| Indopol 500mg CapsulesRegistry verified | Cefadroxil (as Cefadroxil Monohydrate) | — | — | — | 042475Official source ↗ | No indexed price | — | — |
| Indrufen | Ibuprofen | 400 mg/4 mL | Injection | 4mlx10's | 108825 | PKR 1,958.41 | PKR 48.96/mL | 🔒 Pharma Pro |
| Indrufen | Ibuprofen | 400 mg/4 mL | Injection | 4mlx1's | 108825 | PKR 204.00 | PKR 51.00/mL | 🔒 Pharma Pro |
| Indrufen | Ibuprofen | 400 mg/100 mL | IV infusion | 100ml | 108826 | PKR 448.80 | PKR 4.49/mL | 🔒 Pharma Pro |
| Injex | Ceftazidime | 250 mg | Injection | 1's Vial | 030046 | PKR 213.09 | PKR 213.09/vial/unit | 🔒 Pharma Pro |
| Injex | Ceftazidime | 500 mg | Injection | 1's Vial | 030047 | PKR 269.07 | PKR 269.07/vial/unit | 🔒 Pharma Pro |
| Injex | Ceftazidime | 1 g | Injection | 1's Vial | 030048 | PKR 479.56 | PKR 479.56/vial/unit | 🔒 Pharma Pro |
| Injex Plus Injection (IV)Registry verified | Avibactam Sodium Eq. to Avibactam, Ceftazidime Pentahydrate Eq. to Ceftazidime | — | — | — | 137505Official source ↗ | No indexed price | — | — |
| Ironica Injection 500mg/10ml (IV)Registry verified | Ferric Carboxymaltose Eq. to Elemental Iron | — | — | — | 135221Official source ↗ | No indexed price | — | — |
| Ketasol | Ketamine | 250 mg/5 mL | Injection | 5's 5ml Amps. | 013381 | PKR 633.74 | — | No comparator |
| Ketasol | Ketamine | 250 mg/5 mL | Injection | 5 x 2ml Amps. | 013381 | PKR 253.48 | — | No comparator |
| Lecetam | Levetiracetam | 100 mg/mL | Oral solution | 60ml | 112608 | PKR 766.68 | PKR 12.78/mL | 🔒 Pharma Pro |
| Lecetam | Levetiracetam | 100 mg/mL | Oral solution | 10ml | 112608 | PKR 144.82 | PKR 14.48/mL | 🔒 Pharma Pro |
| Lecetam | Levetiracetam | 100 mg/mL | Oral solution | 120ml | 112608 | PKR 1,533.36 | PKR 12.78/mL | 🔒 Pharma Pro |
| Lecetam | Levetiracetam | 100 mg/mL | Oral solution | 15ml | 112608 | PKR 212.97 | PKR 14.20/mL | 🔒 Pharma Pro |
| Lecetam | Levetiracetam | 100 mg/mL | Oral solution | 30ml | 112608 | PKR 404.64 | PKR 13.49/mL | 🔒 Pharma Pro |
| Lecetam | Levetiracetam | 500 mg/5 mL | Injection | 5ml x 10's | 114338 | PKR 6,622.61 | PKR 132.45/mL | 🔒 Pharma Pro |
| Lecetam | Levetiracetam | 500 mg/5 mL | Injection | 5ml x 1's | 114338 | PKR 662.26 | PKR 132.45/mL | 🔒 Pharma Pro |
| Lecetam 250mg TabletsRegistry verified | Levetiracetam ...... 250 mg | — | Tablet | — | 095453Official source ↗ | No indexed price | — | — |
| Lecetam 500mg TabletsRegistry verified | Levetiracetam ...... 500 mg | — | Tablet | — | 095454Official source ↗ | No indexed price | — | — |
| Maxef | Ceftriaxone | 250 mg | IV injection | 1's | 022438 | PKR 287.19 | PKR 287.19/vial/unit | 🔒 Pharma Pro |
| Maxef | Ceftriaxone | 1 g | IV injection | 1's | 022440 | PKR 918.99 | PKR 918.99/vial/unit | 🔒 Pharma Pro |
All 24 Indus Pharma brands in Pakistan
- Canter Clarithromycin · 125 mg/5 mL suspension, 250 mg/5 mL suspension, 500 mg tablet
- Cidpro Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Ciplet Ciprofloxacin · 125 mg/5 mL suspension, 200 mg/100 mL infusion, 250 mg tablet
- Exef Cefotaxime · 250 mg injection
- Explat Clopidogrel · 75 mg tablet
- Flatox Metronidazole · 500 mg infusion
- Indaz Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
- Indolact Lactulose · 66.7 g/100 mL syrup
- Indrufen Ibuprofen · 400 mg/100 mL infusion, 400 mg/4 mL injection
- Injex Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Ketasol Ketamine · 250 mg/5 mL injection
- Lecetam Levetiracetam · 100 mg/mL solution, 500 mg/5 mL injection
- Maxef Ceftriaxone · 1 g injection, 250 mg injection
- Maxnem Meropenem · 1 g injection, 500 mg injection
- Maxpan Cefixime · 200 mg capsule, 400 mg capsule
- Maxpan 100 Oral Cefixime · 100 mg/5 mL suspension
- Metoclon Metoclopramide · 10 mg tablet, 5 mg/5 mL syrup
- Milam Midazolam · 5 mg/5 mL injection, 7.5 mg tablet
- Misartan-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- Mob Moxifloxacin · 400 mg tablet
- OEM Sodium chloride · 2.60 g sachet
- Onseron Ondansetron · 4 mg/2 mL injection, 4 mg/5 mL syrup, 8 mg tablet
- Starlev Levofloxacin · 250 mg tablet, 500 mg tablet
- Veritaz Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
Indus Pharma: common questions
How many products does Indus Pharma have in Pakistan?
Indus Pharma (Pvt.) Ltd has 62 registered medicine presentations in Pakistan, sold under 24 brands and covering 23 generic medicines.
What are the main brands of Indus Pharma?
By number of registered strengths and packs, its largest brands are Lecetam (Levetiracetam), Onseron (Ondansetron), Canter (Clarithromycin), Ciplet (Ciprofloxacin) and Indaz (Azithromycin). This is not a sales ranking.
Which therapy areas does Indus Pharma cover?
The most products are in Anti-infectives (31), Gastrointestinal & hepatology (12), CNS & mental health (9), Pain & musculoskeletal (3) and Anesthesia & critical care (2).
Where can I see Indus Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.